CBT
CRL icon

Crews Bank & Trust’s Charles River Laboratories CRL Stock Holding History

Crews Bank & Trust’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6K Hold
60
– – ﹤0.01% 517
2026
Q1 		$10.3K Hold
60
– – ﹤0.01% 533
2025
Q4 		$12K Hold
60
– – ﹤0.01% 507
2025
Q3 		$9.39K Hold
60
– – ﹤0.01% 526
2025
Q2 		$9.1K Hold
60
– – ﹤0.01% 526
2025
Q1 		$9.03K Hold
60
– – ﹤0.01% 513
2024
Q4 		$11.1K Buy
+60
New +$11.6K ﹤0.01% 495

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Crews Bank & Trust's CRL Position: Q2 2026 in Review

Crews Bank & Trust held its Charles River Laboratories (CRL) position steady in Q2 2026 at 60 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #517.

Crews Bank & Trust first reported a position in CRL in Q4 2024 and has held it in 7 quarters since. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Crews Bank & Trust held 60 shares of Charles River Laboratories worth $13.6K as of Q2 2026.
  • Crews Bank & Trust left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Crews Bank & Trust's portfolio in Q2 2026, its #517 holding.
  • Crews Bank & Trust first reported a position in Charles River Laboratories in Q4 2024 and has held it in 7 quarters since.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Crews Bank & Trust's 13F filing for Q2 2026, filed 16 Jul 2026.